# Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

> **NCT07197775** · — · NOT_YET_RECRUITING · sponsor: **Endogenex, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)
- Type2Diabetes
- Diabetes Mellitus, Type 2
- Type 2 Diabetes
- Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07197775
- **Lead sponsor:** Endogenex, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2032-05
- **Final completion:** 2032-05
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07197775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07197775, "Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07197775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*